Radiotherapy or Radical Prostatectomy Combined With Intense Androgen Deprivation Therapy for Newly Diagnosed Metastatic Prostate Cancer: A Multi-center Randomized Controlled Phase II Trial
Latest Information Update: 03 Jun 2025
At a glance
- Drugs Apalutamide (Primary) ; Darolutamide (Primary) ; Enzalutamide (Primary) ; Rezvilutamide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 03 Jun 2025 New trial record